328 related articles for article (PubMed ID: 28288693)
21. Breakages at YWHAE, FAM22A, and FAM22B loci in uterine angiosarcoma: a case report with immunohistochemical and genetic analysis.
Suzuki S; Tanioka F; Minato H; Ayhan A; Kasami M; Sugimura H
Pathol Res Pract; 2014 Feb; 210(2):130-4. PubMed ID: 24125656
[TBL] [Abstract][Full Text] [Related]
22. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
Oliva E; Clement PB; Young RH
Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
[TBL] [Abstract][Full Text] [Related]
23. YWHAE-NUTM2A/B Translocated High-grade Endometrial Stromal Sarcoma Commonly Expresses CD56 and CD99.
McCluggage WG; Lee CH
Int J Gynecol Pathol; 2019 Nov; 38(6):528-532. PubMed ID: 30252726
[TBL] [Abstract][Full Text] [Related]
24. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
[TBL] [Abstract][Full Text] [Related]
25. Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary.
Klein WM; Kurman RJ
Int J Gynecol Pathol; 2003 Apr; 22(2):181-4. PubMed ID: 12649674
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
Shintaku M; Fukushima A
Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
[TBL] [Abstract][Full Text] [Related]
27. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
[TBL] [Abstract][Full Text] [Related]
28. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract][Full Text] [Related]
29. Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis.
Busca A; Parra-Herran C
Adv Anat Pathol; 2017 Nov; 24(6):354-361. PubMed ID: 28787279
[TBL] [Abstract][Full Text] [Related]
30. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
Rommel B; Holzmann C; Bullerdiek J
Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
[TBL] [Abstract][Full Text] [Related]
32. Morcellating uterine mesenchymal tumors: The pathologist's view.
Pavlakis K; Messini I; Yiannou P; Gavresea T; Chrysanthakis D; Hilaris G; Panoskaltsis T
J Obstet Gynaecol Res; 2017 Mar; 43(3):580-586. PubMed ID: 28120430
[TBL] [Abstract][Full Text] [Related]
33. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Lee CH; MariƱo-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
[TBL] [Abstract][Full Text] [Related]
34. Ovarian high-grade endometrioid stromal sarcoma with YWHAE and NUTM2B rearrangements.
Kikuchi N; Sugita S; Nakanishi K; Sugawara T; Segawa K; Ito Y; Kubo T; Fujita H; Hirano H; Tanaka R; Saito T; Hasegawa T
Pathol Int; 2017 Jun; 67(6):327-329. PubMed ID: 28508463
[No Abstract] [Full Text] [Related]
35. YWHAE Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing.
Aisagbonhi O; Harrison B; Zhao L; Osgood R; Chebib I; Oliva E
Int J Gynecol Pathol; 2018 Sep; 37(5):441-447. PubMed ID: 28863072
[TBL] [Abstract][Full Text] [Related]
36. C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus.
Raspollini MR; Villanucci A; Amunni G; Paglierani M; Taddei A; Taddei GL
J Chemother; 2003 Feb; 15(1):81-4. PubMed ID: 12678420
[TBL] [Abstract][Full Text] [Related]
37. [Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].
Bai QM; Chang B; Tu XY; Bi R; Cheng YF; Huang D; Zhu XL; Wu LJ; Zhang X; Zhou XY; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):769-774. PubMed ID: 29136690
[No Abstract] [Full Text] [Related]
38. Uterine endometrial stromal sarcoma located in uterine myometrium: MRI appearance.
Ueda M; Otsuka M; Hatakenaka M; Torii Y
Eur Radiol; 2000; 10(5):780-2. PubMed ID: 10823633
[TBL] [Abstract][Full Text] [Related]
39. Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma.
Davidson B; Hellesylt E; Holth A; Danielsen HE; Skeie-Jensen T; Katz B
Virchows Arch; 2017 Sep; 471(3):355-362. PubMed ID: 28643014
[TBL] [Abstract][Full Text] [Related]
40. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.
Hoang LN; Aneja A; Conlon N; Delair DF; Middha S; Benayed R; Hensley ML; Park KJ; Hollmann TJ; Hameed MR; Antonescu CR; Soslow RA; Chiang S
Am J Surg Pathol; 2017 Jan; 41(1):12-24. PubMed ID: 27631520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]